HAHSTA - FY14 Pharmaceutical Services

The District of Columbia's HIV/AIDS Administration (HAHSTA) is seeking pharmaceutical services for fiscal year 2014, with a contract opportunity focusing on specialized medical procurement. This solicitation appears to target comprehensive pharmaceutical service providers capable of delivering complex medical supply and distribution solutions. The procurement involves a narrow window for response, with the posting date of March 25, 2014, and a critically short response deadline of March 28, 2014, indicating an urgent procurement timeline. While specific detailed requirements are not fully enumerated in the provided excerpt, the contract suggests a targeted pharmaceutical service need for the District's public health infrastructure. The brevity of the submission period implies a potentially streamlined selection process with expedited evaluation criteria.

Given the limited information provided, potential restrictions or set-aside designations cannot be definitively confirmed. The contract appears to be a District of Columbia government procurement, which typically encourages participation from local, small, and disadvantaged business enterprises. The procurement is specifically associated with HAHSTA's pharmaceutical services for fiscal year 2014, suggesting potential involvement of health-focused vendors with demonstrated capabilities in medical supply distribution. Without additional context, precise award values or budget ranges remain unspecified. The contract's short turnaround time and specific focus on pharmaceutical services indicate a targeted, time-sensitive procurement approach by the District of Columbia's municipal government.